Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;3(5):291-8.
doi: 10.1177/2040620712453596.

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia

Affiliations

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia

Nichola Cooper et al. Ther Adv Hematol. 2012 Oct.

Abstract

Romiplostim is a thrombopoietin peptide mimetic agent recently approved for the treatment of adults with chronic immune thrombocytopenia (ITP). In randomized controlled studies, this agent has demonstrated an increase in the platelet count in the majority of patients with ITP, both in splenectomized and nonsplenectomized patients. In up to 5 years of follow up, its safety profile has been favorable, suggesting this could be a novel therapeutic agent in patients with ITP. This article summarizes the development of this new agent and explores its safety and efficacy in adults with chronic ITP.

Keywords: AMG-531; immune thrombocytopenia; romiplostim; thrombopoietin; thrombopoietin-mimetic agents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ballem P., Segal G., Stratton J., Gernsheimer T., Adamson J., Slichter S. (1987) Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80: 33–40 - PMC - PubMed
    1. Bao W., Bussel J., Heck S., He W., Karpoff M., Boulad N. (2010) Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 116: 4639–4645 - PMC - PubMed
    1. Branehog I., Kutti J., Weinfeld A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 27: 127–143 - PubMed
    1. Branehog I., Weinfeld A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand J Haematol 12: 69–79 - PubMed
    1. Broudy V., Lin N. (2004) AMG 531 stimulates megakaryopoiesis in vitro by binding to MPL. Cytokine 25: 52–60 - PubMed

LinkOut - more resources